Search
Now showing items 1-10 of 17
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: The authors' reply
(Nature Publishing Group, 2016)
Cytogenetic effect of 5-azacytidine in patients with hematological malignancies
(Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2011-10-01)
BACKGROUND: Recently, the importance of cytogenetics has grown in the diagnosis, prognosis and treatment of leukemias and myelodysplastic syndromes. 5-azacytidine is a drug that has well-known cytogenetical effects and is ...
Chromosome damage induced by 5-azacytidine under the influence of caffeine or cytosine arabinoside in CHO-K1 (wild-type) and XRS-5 (mutant) cell lines
(2001-07-14)
5-azacytidine (5-azaC) treatment combined with cytosine arabinoside (ara-C) or caffeine were performed in vitro in Chinese hamster cells, CHO-K1 (wild-type) and xrs-5 (mutant) cell lines, in order to compare the cell ...
Chromosome damage induced by 5-azacytidine under the influence of caffeine or cytosine arabinoside in CHO-K1 (wild-type) and XRS-5 (mutant) cell lines
(2001-07-14)
5-azacytidine (5-azaC) treatment combined with cytosine arabinoside (ara-C) or caffeine were performed in vitro in Chinese hamster cells, CHO-K1 (wild-type) and xrs-5 (mutant) cell lines, in order to compare the cell ...
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish registry
(Nature Publishing Group, 2015)
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
(Nature Publishing GroupLondonInglaterra, 2014)
Estudio de genes codificantes para enzimas policétido sintasa de la cepa fúngica antártica Pseudogymnoascus sp. 131209-E2A-C5II-EB
(Universidad de Chile., 2019-04)
Los hongos filamentosos de ambientes extremos son fuentes promisorias de metabolitos secundarios de carácter novedoso. En particular, el género fúngico Pseudogymnoascus, que habita distintos ambientes fríos, entre ellos ...
Pre-Treatment Risk Assessment for Elderly Patients with Acute Myeloid Leukemia
(ElsevierEstados Unidos, 2018-09)
The treatment of AML in older adults is limited by the
high mortality related with induction chemotherapy; however, those
who tolerate an intensive treatment will have better outcomes;
therefore, selecting this group ...